Advertisement

Let’s learn from our neighbors from the North as we get the menthol flavor out of cigarettes

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

In the trenches on the medicine wards and smoking cessation clinics at Parkland Hospital  and UT Southwestern Simmons Cancer Center, I see firsthand the increased prevalence of smoking in the Black population, their frequent use of menthol, and the ravaging toll it takes on their health.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Advertisement
Advertisement
David Balis, MD
Director, Smoking Cessation Clinics, Parkland Hospital, UT Southwestern Simmons Cancer Center; Professor, General Internal Medicine, UT Southwestern
Table of Contents
Advertisement
Advertisement

YOU MAY BE INTERESTED IN

When Helene Brown, a cancer control pioneer who jokingly described herself as “the first in a long line of political oncologists,” delivered the keynote address at the Oncology Nursing Society annual meeting in 1990, she set forth bold predictions for the ensuing 20 years of the field: appointments conducted over “computerphone,” major genetic breakthroughs, and universal healthcare.
FDA granted traditional approval to Merck’s pembrolizumab (Keytruda) with trastuzumab, fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of adults with locally advanced unresectable or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma whose tumors express PD-L1 (CPS ≥1).
Advertisement
Advertisement